At the Canadian Medical Isotope Ecosystem (CMIE), our mission is to position Canada as a global leader in medical isotope innovation by:
Accelerating research and development investment
Promoting cross-country collaboration
Nurturing talent
Leading the Way in Medical Isotope Innovation
CMIE is in its early stages, and we’re poised for growth. Our journey is fueled by a vision to create a thriving ecosystem that pioneers ground-breaking advancements in medical isotopes, allowing Canada to lead and succeed in the nuclear medicine world.
Funding initiatives: Building the Future Together
We are proud to share that we have secured matched funding from Innovation, Science, and Economic Development Canada (ISED)’s Strategic Innovation Fund (SIF). This support has allowed CMIE to create a Development Fund, enabling us to invest in Canadian programs led by industry leaders and emerging innovators.
The Canadian Medical Isotope Ecosystem Development Fund (CMIEDF), aims to forge collaborations and partnerships that advance medical isotope supply and technologies for enhanced radiotherapeutics and radiodiagnostics.
In the spirit of industry collaboration, the CMIE will leverage the Canadian Nuclear Isotope Council to support the delivery of the CMIEDF.
First round of funding: We have allocated our first round of funding to support five transformative projects. These initiatives represent the cornerstone of our commitment to fostering innovation and research excellence in the medical isotope sector.
Next round of funding: In our upcoming second round of funding, we are actively seeking early-stage research programs with the intention of propelling promising projects toward clinical trials. We believe in investing in the future of medical isotopes to improve the health of Canadians. Subscribe to our community for notifications on next round of funding.